Finally, there is no established adjuvant and neoadjuvant therapy although a few early phase studies show promising results. In this chapter, we summarize current approaches of systemic treatment in patients with liver cancer.Advances in Cancer Research...
which in turn provides opportunities for the development of novel molecular targeted agents that inhibit molecular abnormalities as promising cancer treatments [9]. At present, molecular targeted therapy mainly includes tyrosine
Cancer therapy Clinical trials Liver cancer This article is cited by DNA methylation of ACADS promotes immunogenic cell death in hepatocellular carcinoma Ze Qian Yifan Jiang Diyu Chen Cell & Bioscience(2025) CK19 protein expression: the best cutoff value on the prognosis and the prognosis model of...
Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12, 253–268 (2012). Article CAS PubMed PubMed Central Google Scholar Jaillon, S. et al. Neutrophil diversity and plasticity in tumour progression and therapy. Nat. Rev. Cancer 20, 485–503 (2020). Article CAS Pub...
and Shigeaki Yoshida Division of Digestive Endoscopy and Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Chiba 277-8557, Japan Abstract We report a patient with liver metastasis from gastric cancer who has achieved a 5-year survival after systemic chemo- therapy....
SystemicTherapyforHepatocellularCarcinoma:CytotoxicChemotherapy,TargetedTherapyandImmunotherapy MelanieB.Thomas(MD)1JamesP.OÕBeirne(MD)2JunjiFuruse(MD)3nthonyT.C.Chan(MD)4GhassanAbou-Alfa(MD)5andPhilipJohnson,MD6 1DepartmentofGastrointestinalMedicalOncology,TheUniversityofTexasMDAndersonCancerCenter,1515Holcomb...
and The therapy of cancer is, in reality, the design of therapeutic strategies for therapy of metastatic disease. Metastases consist of unique subpopulations of tumor cells that are derived from the primary tumor, colonize distant target organs, and are able to subvert host immune responses, establ...
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6). BMC Cancer....
- 《American Journal of Clinical Oncology Cancer Clinical Trials》 被引量: 2发表: 2017年 Selective Internal Yttrium-90 Radioembolization Therapy (Y-90-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Li... Minzhi, Xing,Hasmukh J,etc.Selective Internal ...
The WHI study of estrogen plus progestin reported increased risks of MI, stroke, invasive breast cancer, pulmonary embolism, and DVT in postmenopausal women receiving >5 years of therapy with conjugated estrogens 0.625 mg in conjunction with medroxyprogesterone acetate 2.5 mg daily. The WHI Memory St...